Literature DB >> 17520236

[Long-term follow-up on alcohol use in a big company after brief intervention by a company physician].

B Croissant1, K Hupfer, S Loeber, K Mann, A Zober.   

Abstract

BACKGROUND: Many examinations have shown that brief medical interventions are useful when seeking to influence the drinking behavior of problem drinkers and alcohol-dependent subjects. The working environment is particularly useful when trying to influence problematic drinking behavior. Our report is about the long-term effects on alcoholic employees.
METHODS: The drinking behavior of 100 employees was categorized according to WHO criteria. By motivational interviewing, the employees were asked to reduce their alcohol consumption or quit completely and then come back at a later control date. The data collected was: drinking behavior (TLFB, time-line follow-back), biological markers (GGT, CDT, MCV), changes in personal situations, and the factors and reasons involved.
RESULTS: Forty-five percent of the employees went to their company physician after recommendation by their supervisors, and 24% went on their own initiative. Of the employees examined, 82% were diagnosed as being alcohol-dependent, 4% as harmful abusers, 6% as risky drinkers, and 8% as questionably risky drinkers. At the time of catamnesis, 78% of the employees that were originally diagnosed as alcohol-dependent were abstinent. Of those participants, 17% that were initially classified as not dependent were abstinent, and the overall quantity of alcohol consumed was also reduced significantly by 79.3%. Personal realms especially concerning happiness in life, happiness at work, and physical health improved.
CONCLUSION: The results show that a brief medical intervention conducted by a company physician is suited to influencing the drinking behavior of employees effectively and efficiently. The fear of demotion at work and job loss may prove to be a helpful influence on changing drinking behavior.

Entities:  

Mesh:

Year:  2008        PMID: 17520236     DOI: 10.1007/s00115-007-2275-3

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  5 in total

1.  Empirically supported psychological interventions: controversies and evidence.

Authors:  D L Chambless; T H Ollendick
Journal:  Annu Rev Psychol       Date:  2001       Impact factor: 24.137

2.  [The qualified-detoxification-of-alcoholics procedure--in light of the development of guidelines for the treatment of substance-related disorders].

Authors:  Lutz G Schmidt; Götz Mundle; Markus Banger; Friedhelm Stetter; Michael Soyka; Clemens Veltrup; Karl Mann
Journal:  Z Arztl Fortbild Qualitatssich       Date:  2002-06

3.  Five-year reliability of self-reported alcohol consumption.

Authors:  D M Czarnecki; M Russell; M L Cooper; D Salter
Journal:  J Stud Alcohol       Date:  1990-01

4.  [Drug addiction prevention in the workplace--feasibility study in a company from the chemical industry].

Authors:  B Croissant; O Klein; S Löber; K Mann
Journal:  Gesundheitswesen       Date:  2004 Aug-Sep

Review 5.  Diagnostic tests for alcohol consumption.

Authors:  K M Conigrave; J B Saunders; J B Whitfield
Journal:  Alcohol Alcohol       Date:  1995-01       Impact factor: 2.826

  5 in total
  3 in total

Review 1.  [Drinking behavior at the beginning and during the SARS-CoV-2 pandemic: results of a literature review].

Authors:  Beatrice Thielmann; Irina Böckelmann; Heiko Schumann
Journal:  Notf Rett Med       Date:  2022-04-29       Impact factor: 0.892

2.  [Treatment outcome after inpatient alcohol withdrawal: impact of motivational interventions: a comparative study].

Authors:  S Loeber; F Kiefer; F Wagner; K Mann; B Croissant
Journal:  Nervenarzt       Date:  2009-09       Impact factor: 1.214

3.  Can Motivational Interviewing Make a Difference in Supporting Employees to Deal with Elevated Blood Pressure? A Feasibility Study at the Workplace.

Authors:  Martina Michaelis; Carmen Witte Née Farian; Barbara Schüle; Katrin Frick; Monika A Rieger
Journal:  Int J Environ Res Public Health       Date:  2021-04-15       Impact factor: 3.390

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.